ENDOVASCULAR TREATMENT AND THROMBOLYSIS IN ISCHEMIC STROKE PATIENTS (EVA-TRISP)
Research Project | 01.01.2020
The major aim of EVA-TRISP is to address clinically important questions about safety and outcomes in AIS patients treated with IVT and/or EVT that are not covered by RCTs. The idea of EVA-TRISP is that experienced stroke centres with a record and expertise in both: (1) usage of IVT and/or EVT and (2) maintenance of hospital-based
stroke databases pool their data. In addition to the characteristics of the EVA-TRISP centres stated previously, an advantage of EVA-TRISP is the availability of more additional variables than in other large-scale registries and the commitment by the collaborators to: (1) submit accurate and complete data and to (2) be willing to adapt the local databases and quickly add new variables retrospectively and prospectively.
Publications
Traenka, Christopher et al. (2023) ‘Recanalization Therapies for Large Vessel Occlusion Due to Cervical Artery Dissection: A Cohort Study of the EVA-TRISP Collaboration’, Journal of Stroke, 25, pp. 272–281. Available at: https://doi.org/10.5853/jos.2022.03370.
Filioglo A et al. (2022) ‘Outcomes after reperfusion therapies in patients with ACA stroke: A multicenter cohort study from the EVATRISP collaboration.’, Journal of the neurological sciences, 432, p. 120081. Available at: https://doi.org/10.1016/j.jns.2021.120081.
Filioglo A et al. (2022) ‘Tandem occlusions involving the internal carotid and anterior cerebral arteries-A rare form of stroke: Results from the multicenter EVATRISP collaboration study.’, Frontiers in neurology, 13, p. 1024891. Available at: https://doi.org/10.3389/fneur.2022.1024891.
Nordanstig A et al. (2021) ‘EndoVAscular treatment and ThRombolysis for Ischemic Stroke Patients (EVA-TRISP) registry: basis and methodology of a pan-European prospective ischaemic stroke revascularisation treatment registry.’, BMJ open, 11(8), p. e042211. Available at: https://doi.org/10.1136/bmjopen-2020-042211.
Members (2)
Stefan Engelter
Co-PI